/Zoetis%20Inc%20HQ%20sign-by%20JHVEPhoto%20via%20Shutterstock.jpg)
Valued at a market cap of $67.6 billion, Zoetis Inc. (ZTS) is a global leader in animal health. The company develops, manufactures, and commercializes medicines, vaccines, diagnostics, biodevices, genetic tests, and precision animal health solutions for both livestock and companion animals.
Companies valued at $10 billion or more are generally considered "large-cap" stocks, and Zoetis fits this criterion perfectly. With a diversified portfolio and strategic collaborations, Zoetis continues to expand its reach, driven by rising pet ownership, increased spending on animal care, and innovation in veterinary health.